iBio, Inc. (IBIO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$5.34M2012: -$6.01M2013: -$4.85M2017: -$13.16M2018: -$13.48M2019: -$13.97M2020: -$13.35M2021: -$30.06M2022: -$37.48M2023: -$30.44M2024: -$18.55M2025: -$15.30M-$15.30M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$15.30M+17.5%
2024-$18.55M+39.0%
2023-$30.44M+18.8%
2022-$37.48M-24.7%
2021-$30.06M-125.3%
2020-$13.35M+4.5%
2019-$13.97M-3.7%
2018-$13.48M-2.4%
2017-$13.16M
2013-$4.85M+19.3%
2012-$6.01M-12.6%
2011-$5.34M